BiotechTube
Home/Wugen/Matthew Cooper
MC

Matthew Cooper

Co-Founder & Chief Scientific Officer

Wugen

Therapeutic Areas

OncologyHematologic MalignanciesAutoimmune Diseases

Wugen Pipeline

DrugIndicationPhase
WU-CART-007 (Soficabtagene Geleucel)Relapsed/Refractory T-ALL / T-LBLPivotal Trial
CAR-T (Allogeneic)T-NHLClinical

Leadership Team at Wugen

KS
Kumar Srinivasan
President & Chief Executive Officer
CT
Cherry Thomas
Chief Medical Officer
View full Wugen profile